Alexion Pharmaceuticals Inc Revenue per Employee (ALXN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Alexion Pharmaceuticals Inc   (NASDAQ: ALXN)
 

Alexion Pharmaceuticals Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 13.27% in the first quarter 2021, year on year to cumulative value of $6,262 million, Alexion Pharmaceuticals Inc 's revenue per employee grew on a trailing twelve months basis to $ 1,631,900. The productivity of Alexion Pharmaceuticals Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector employees in only one company have achieved higher revenue/employee than at Alexion Pharmaceuticals Inc . While Alexion Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 28 to 85. Alexion Pharmaceuticals Inc has 3,837 employees.


What is Sales per Employee Ratio?







ALXN Revenue per Employee (Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Revenue Change 13.27 % 14.99 % 25.78 % 20.05 % 26.69 %
Sales per Employee (TTM) $ 1,631,900 1,581,939 1,527,860 1,443,002 1,380,115
ALXN's Total Ranking # 85 # 28 # 11 # 43 # 56
Seq. Revenue Change 2.81 % 0.2 % 9.98 % -0.01 % 4.37 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 2
Healthcare Sector # 2
Overall Market # 85

Revenue per Employee Statistics
High Average Low
$ 2,031,668 $ 1,113,638 $ 398,547
(Mar 31 2021)   (March 31, 2013)



Financial Statements
Alexion Pharmaceuticals Inc 's Revenue MRQ $ 1,637 Millions Visit ALXN's Income Statement
Alexion Pharmaceuticals Inc 's Revenues TTM $ 6,262 Millions Visit ALXN's aggregate revenue growth
What are ALXN's Sales? Visit ALXN's Sales by Segment




Other Ratios
Alexion Pharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ALXN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ALXN's Competitors
Revenue per Employee for ALXN's Suppliers
Revenue per Employee for ALXN's Customers

You may also want to know
ALXN's Sales Growth Rates ALXN's Pe Price to earnings ratio ALXN's Receivables Turnover Ratio ALXN's Stock Quote
ALXN's Net Income Growth Rates ALXN's Ps Price to Sales ratio ALXN's Sales per Employee ALXN's Asset Turnover Ratio
ALXN's Net Margin ALXN's Pb Price to Book ratio ALXN's Financial Strength Ratios ALXN's Dividend Payout Ratio
Date modified: 2026-09-12T06:12:03+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2021, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2021Number of Employees Mar 31 2021
Kala Bio inc   2,852,333.33 $ 8.557  Million 3 
Illumina Inc   2,713,281.25 $ 3,473.000  Million 1,280 
Siga Technologies Inc  2,594,964.96 $ 127.153  Million 49 
Veru Inc   2,501,420.80 $ 50.028  Million 20 
Vyne Therapeutics Inc   2,336,200.00 $ 23.362  Million 10 
Innoviva Inc   2,161,220.13 $ 343.634  Million 159 
Assertio Holdings inc   2,116,924.53 $ 112.197  Million 53 
Xoma Royalty Corporation  2,068,285.71 $ 28.956  Million 14 
Nektar Therapeutics  1,999,825.40 $ 125.989  Million 63 
Scienture Holdings Inc   1,996,937.22 $ 17.972  Million 9 
Amgen Inc   1,935,692.31 $ 25,164.000  Million 13,000 
Emergent Biosolutions Inc   1,933,222.22 $ 1,739.900  Million 900 
Seagen Inc   1,894,170.83 $ 2,273.005  Million 1,200 
Journey Medical Corp  1,695,586.21 $ 98.344  Million 58 
Horizon Therapeutics Public Limited Company  1,682,250.77 $ 2,186.926  Million 1,300 
Biogen Inc   1,680,573.33 $ 12,604.300  Million 7,500 
Prestige Consumer Healthcare Inc   1,655,026.32 $ 943.365  Million 570 
Alexion Pharmaceuticals Inc   1,631,899.92 $ 6,261.600  Million 3,837 
Sunwin Stevia International Inc.  1,586,177.19 $ 25.379  Million 16 
Eagle Pharmaceuticals inc   1,564,367.52 $ 183.031  Million 117 
Sorrento Therapeutics Inc   1,550,666.67 $ 46.520  Million 30 
Puma Biotechnology Inc   1,519,899.44 $ 272.062  Million 179 
Acorda Therapeutics Inc   1,507,156.86 $ 153.730  Million 102 
Gilead Sciences Inc   1,503,764.71 $ 25,564.000  Million 17,000 
Prophase Labs Inc   1,468,263.16 $ 27.897  Million 19 
Blueprint Medicines Corporation  1,397,898.63 $ 813.577  Million 582 
Morphic Holding inc   1,374,709.68 $ 42.616  Million 31 
Semler Scientific inc   1,366,322.58 $ 42.356  Million 31 
Akebia Therapeutics Inc   1,335,737.11 $ 259.133  Million 194 
Bristol myers Squibb Company  1,317,230.77 $ 42,810.000  Million 32,500 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.